MaaT Pharma SA logo

MaaT Pharma SA

EPA:MAAT.PA

Overview | Financials
Company Name MaaT Pharma SA
Symbol MAAT.PA
Currency EUR
Price 7.24
Market Cap 100,585,110
Dividend Yield 0%
52-week-range 6 - 9.9
Industry Biotechnology
Sector Healthcare
CEO Mr. Herve Affagard
Website https://www.maatpharma.com

An error occurred while fetching data.

About MaaT Pharma SA

MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials

Related Stocks

MDxHealth SA logo

MDxHealth SA

MDXH.BR

3.02 EUR

Novacyt S.A. logo

Novacyt S.A.

ALNOV.PA

0.669 EUR

OSE Immunotherapeutics SA logo

OSE Immunotherapeutics SA

OSE.PA

8.98 EUR

Amplitude Surgical SA logo

Amplitude Surgical SA

AMPLI.PA

3.18 EUR

Sequana Medical NV logo

Sequana Medical NV

SEQUA.BR

0.96 EUR

Eurofins-Cerep SA logo

Eurofins-Cerep SA

ALECR.PA

19,100 EUR

Fermentalg SA logo

Fermentalg SA

FALG.PA

0.56 EUR

GenSight Biologics S.A. logo

GenSight Biologics S.A.

SIGHT.PA

0.385 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD